Edwards Lifesciences Retained Earnings (Accumulated Deficit) 2010-2025 | EW
Edwards Lifesciences retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $13.525B, a 44.74% increase year-over-year.
- Edwards Lifesciences retained earnings (accumulated deficit) for 2024 were $13.167B, a 46.42% increase from 2023.
- Edwards Lifesciences retained earnings (accumulated deficit) for 2023 were $8.992B, a 18.48% increase from 2022.
- Edwards Lifesciences retained earnings (accumulated deficit) for 2022 were $7.59B, a 25.08% increase from 2021.